切換帳號

  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 登入

全站搜尋

台灣泌尿科醫學會E-School
  • 登入
  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 到官網
  • Home
  • 到官網
  • Home
知識庫
  • 目錄總覽
  • 文件總覽
  • 最新討論
目錄 / 資料夾
  • 學術活動與演講
    • 年會
      • 2025半年會
        • 摘要
      • 2024年會
        • 摘要
      • 2024半年會
        • 摘要
      • 2023年會
        • 摘要
      • 2023半年會
        • 摘要
      • 2022年會
        • 摘要
      • 2021年會
        • 摘要
      • 2021半年會
        • 摘要
      • 2020年會
        • 摘要
      • 2020半年會
        • 摘要
      • 2019年會
        • 摘要
      • 2019半年會
        • 摘要
      • 2018年會
        • 摘要
      • 2018半年會
        • 摘要
      • 2017年會
        • 摘要
      • 2017半年會
        • 摘要
      • 2016年會
        • 摘要
      • 2016半年會
        • 摘要
      • 2015年會
        • 摘要
  • 新手指南與FAQ
  1. 知識庫
  2. 最新上傳

最新上傳
(
  • 熱門
)

最新上傳

(
  • 熱門
)
PD09-3: The incidence and multiplex nomogram for prediction of metachronous and synchronous upper tract urothelial cancer in patients with non-muscle invasive urinary bladder cancer
2023-07-05
PD09-4: Impact of erythropoiesis-stimulating agents on patients with end stage renal disease and early-stage urothelial carcinoma: A real-world study
2023-07-05
PD09-5: The Effects of Cyproheptadine in Eliciting Natural Killer cell-mediated Immune Response in Bladder Cancer
2023-07-05
PD09-6: Down-regulation of Aquaporins Sensitizes Atezolizumab-induced Cytotoxicity of urothelial carcinoma
2023-07-05
PD09-2: Is the native upper urinary tract urothelial carcinoma different between dialysis patients and renal transplant recipients?
2023-07-05
PD09-1: Recruitment of lymphatic endothelial cells by thrombospondin-4 induces lymphangiogenesis in human bladder tumors
2023-07-05
PD02-6: Comparison of the adverse events between 2 different BCG strains in patients receiving intravesical therapy for non-muscle invasive bladder urothelial carcinoma: A single center experience
2023-07-05
PD02-5: The farnesoid X receptor agonist GW4064 inhibits migration and invasion through β-catenin and MMP2 downregulation in human bladder cancer
2023-07-05
PD02-4: The prognostic significance of CEBPD expression in patients with bladder urothelial carcinoma
2023-07-05
PD02-3: Urinary Exfoliated Cells as a Potential Biomarker for Urothelial Carcinoma
2023-07-05
PD02-2: GDF15/prothymosin α signaling disruption as a potential therapy for muscle wasting in bladder cancer patients treated with cisplatin
2023-07-05
PD02-1: Ferroptosis induction and glutathione peroxidase 4 suppression as mechanisms of Evodiamine's inhibition to high grade bladder cancer cell
2023-07-05
PD01-6: Analyzing the effects of testosterone level on nocturia in prostate cancer patients receiving androgen deprivation therapy
2023-07-05
PD01-5: The efficacy of behavioral therapy and different dosage of β3-adrenoceptor agonist treatment for male overactive bladder patients, a comparison study
2023-07-05
PD01-4: Normal post void residual urine in healthy adults
2023-07-05
PD01-3: Complication Analysis of Transurethral Resection of Prostate Under Different Types of Anesthesia: A Nationwide, Population-based Cohort Study
2023-07-05
PD01-2: Low Intensity Extracorporeal Shockwave Targeting at Dorsal Root Ganglion Attenuate Nociceptive Markers and BOLD activity in a Rat Model of Nonbacterial Chronic Prostatitis
2023-07-05
PD01-1: The diagnostic rule of prostatic urethral angle in diagnosis of bladder neck dysfunction in men with lower urinary tract symptoms and small prostate volume
2023-07-05
NPD84: Retrograde intrarenal surgery for a complete renal staghorn stone: a case report
2023-07-05
NPD83: Pediatric spina bifida combined with neurogenic bladder: A case report
2023-07-05
NPD82: Non-negligible complication during transurethral resection of the prostate, hyperchloremic metabolic acidosis: a case report and review of literature
2023-07-05
NPD81: Spontaneous renal pelvis rupture caused by distal ureteral stone
2023-07-05
NPD80: Testicular Abscess - An Extrapulmonary Manifestation of Tuberculosis
2023-07-05
NPD79: Large bladder stones with concurrent urethral steinstrasse: A rare case report
2023-07-05
  • <
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • >
/ 127
地址:台北市 11051 信義區基隆路一段432號6樓之1, 電話:02-2729-0819, 傳真:02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw